Drugs of Abuse Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Drug of Abuse Testing Market By Product Type (Analyzers, Rapid Testing Devices and Consumables), Sample Type (Saliva, Urine, Blood and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories and Other End Users) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The drug of abuse testing market is valued at USD 2.7 billion in 2021 and is poised to grow at a significant CAGR of 5.6% over 2022–2028. Drug abuse testing is frequently employed in forensic and clinical settings. Drug testing has increased in popularity in recent years and is frequently covered in the media. Drug testing is still done in athletics and sports today, but it is becoming more frequent in business, education, the military, retail, and public places. New technologies are being developed to speed up and improve the effectiveness of drug testing in order to meet the rising demand for such testing. Drug tests can now be administered on-site by certified personnel, with results being available in only a few minutes. The rise in the number of clinical laboratories offering drug abuse testing services has contributed to the market’s progress. The market for drug abuse testing services is also anticipated to benefit from a significant rise in the number of physician laboratories, hospital-based laboratories, retail clinics, and independent laboratories that collect samples and conduct drug screening tests. Drug abuse testing has increased over the past few years. An automated analyzer is used in a hospital laboratory to perform medical drug testing. The leading players in the market are acquiring or working with other companies to gain a more significant stake in the market as a result of the companies’ growing interest in the industry.

Recent Market Developments:

In Sept 2019, A new distribution contract was signed by Psychemedics Corporation with Toxicologia Pardini Ltda. and Sanso Holding S.A. in Brazil. Toxicologia Pardini and Sanso was chosen as the Brazilian distributor for Psychemedics’ hair drug testing services under the terms of the new deal.

Drugs of Abuse Testing Market

MARKET SUMMARY
-
5.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Drugs of Abuse Testing Market

  • The report on global drug of abuse testing market gives historical, current and future market sizes (US$ Mn) based on the drug, test type, sample, end user and geographical regions
  • drug of abuse testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Drägerwerk AG & Co.
  • Hoffmann-La Roche Ltd.
  • Danaher Corporation
Drugs of Abuse Testing Market Drivers

Urine drug testing is routinely utilised in clinical, employment, educational, and legal contexts, and incorrect results interpretation can have serious negative effects on the person being tested. Clinicians face difficulties when trying to correctly interpret urine drug test results because of improvements in drug testing technology as well as an increase in the number of novel chemicals that are abused. Because urine testing is rapid, noninvasive, and capable of detecting a wide range of substances, it is the most popular. Depending on the medication used, it may be able to detect medicines that were used within the last 1 to 4 days, or even longer. Recent scientific advancements in the equipment and materials used to test urine samples for drugs of abuse have made these tests, when properly executed, highly accurate for cannabis and cocaine, the two most common drugs of abuse.


North-America got significant share

Drugs of Abuse Testing Market

The Drug of Abuse Testing market in North America is likely to hold a significant revenue share in 2021, and, in the following years, it is predicted to increase rapidly due to the increase in the usage of illegal drugs in this area. The US government is putting in place a number of measures to monitor the signs and decide whether a person is abusing drugs. For instance, the country implemented the Patients and Communities Act of 2018 as a law to combat drug usage. Also, as a result of rising drug addiction in the region, Asia Pacific is anticipated to develop at the fastest rate during the projection period. The market for drug testing equipment in the Asia Pacific region has strong potential due to growing economies like China and India.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The drug of abuse testing market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Drugs of Abuse Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The drug of abuse testing market is projected to expand at a CAGR of 5.6% during the forecast period.

Siemens Healthineers, Thermo Fisher Scientific Inc., Drägerwerk AG & Co., Hoffmann-La Roche Ltd., Danaher Corporation

North America is the fastest-growing region for drug of abuse testing market


Report

Table Of Content


Report

Company Profile

  • Danaher Corporation
  • LabCorp
  • Abbott Laboratories
  • Quest Diagnostics, Inc.
  • Cordant Health Solutions
  • DrugScan
  • Legacy Medical Services
  • Mayo Clinic Laboratories
  • LGC Group
  • Precision Diagnostics

Description

The drug of abuse testing market is valued at USD 2.7 billion in 2021 and is poised to grow at a significant CAGR of 5.6% over 2022–2028. Drug abuse testing is frequently employed in forensic and clinical settings. Drug testing has increased in popularity in recent years and is frequently covered in the media. Drug testing is still done in athletics and sports today, but it is becoming more frequent in business, education, the military, retail, and public places. New technologies are being developed to speed up and improve the effectiveness of drug testing in order to meet the rising demand for such testing. Drug tests can now be administered on-site by certified personnel, with results being available in only a few minutes. The rise in the number of clinical laboratories offering drug abuse testing services has contributed to the market’s progress. The market for drug abuse testing services is also anticipated to benefit from a significant rise in the number of physician laboratories, hospital-based laboratories, retail clinics, and independent laboratories that collect samples and conduct drug screening tests. Drug abuse testing has increased over the past few years. An automated analyzer is used in a hospital laboratory to perform medical drug testing. The leading players in the market are acquiring or working with other companies to gain a more significant stake in the market as a result of the companies’ growing interest in the industry.

Recent Market Developments:

In Sept 2019, A new distribution contract was signed by Psychemedics Corporation with Toxicologia Pardini Ltda. and Sanso Holding S.A. in Brazil. Toxicologia Pardini and Sanso was chosen as the Brazilian distributor for Psychemedics’ hair drug testing services under the terms of the new deal.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX